Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Astria Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ATXS is no longer listed, and 13F filings after Q4 2025 list far fewer holders. See Q4 2025
- Institutional holders
- 0
- −139 vs. Q4 2025
- Shares held
- 0
- −52.9M (−100.0%) vs. Q4 2025
- Total value
- $0
- −$690.4M (−100.0%) vs. Q4 2025
- New holders
- 0
- 0 more added
- Sold out
- 139
- 0 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −8,654−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −8,067−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −6,462−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −5,640−100.0% | Sold out |
| Seven Fleet Capital Management LP | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −3,714−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,257−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,067−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −2,546−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −2,383−100.0% | Sold out |
| 1620 Investment Advisors, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −1,935−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,353−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,299−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,187−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −620−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −443−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −298−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −174−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Basecamp Wealth Advisors LLC | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Cornerstone Financial Management LLC | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Key Financial Inc | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Rialto Wealth Management, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Omni Event Management Ltd | – | – | – | – | Not filed |